The tale of TILs in breast cancer: A report from The International Immuno-Oncology Biomarker Working Group
2021 · npj Breast Cancer · 257 citations
https://doi.org/10.1038/s41523-021-00346-1
M
Mieke Van Bockstal
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
163
Papers
2.8K
Citations
27
h-index
55
i10-index
Mieke Van Bockstal is an academic researcher from Cliniques Universitaires Saint-Luc. The author has contributed to research in topics: Breast Cancer Treatment Studies & HER2/EGFR in Cancer Research & Cancer Immunotherapy and Biomarkers. The author has an h-index of 27, co-authored 139 publications.
ORCID: 0000-0003-4498-928XPapers by this author
worksPitfalls in assessing stromal tumor infiltrating lymphocytes (sTILs) in breast cancer
2020 · npj Breast Cancer · 198 citations
https://doi.org/10.1038/s41523-020-0156-0
Cancer-Associated Adipose Tissue Promotes Breast Cancer Progression by Paracrine Oncostatin M and Jak/STAT3 Signaling
2014 · Cancer Research · 139 citations
https://doi.org/10.1158/0008-5472.can-14-0160
Distinguishing Score 0 From Score 1+ in HER2 Immunohistochemistry-Negative Breast Cancer
2013 · American Journal of Clinical Pathology · 93 citations
https://doi.org/10.1309/ajcp4a7ktayhzsoe
HER2-Low Breast Cancer: Incidence, Clinicopathologic Features, and Survival Outcomes From Real-World Data of a Large Nationwide Cohort
2023 · Modern Pathology · 40 citations
https://doi.org/10.1016/j.modpat.2022.100087
Metabolic adaptation towards glycolysis supports resistance to neoadjuvant chemotherapy in early triple negative breast cancers
2024 · Breast Cancer Research · 23 citations
https://doi.org/10.1186/s13058-024-01788-8
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat